Stereotaxis Inc Share Price Nasdaq
Equities
US85916J4094
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.16 USD | +57.66% | -2.84% | +71.25% |
05-13 | Transcript : Stereotaxis, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
05-13 | Stereotaxis to Buy Access Point Technologies | MT |
Sales 2024 * | 29.5M 2.33B | Sales 2025 * | 44.25M 3.49B | Capitalization | 172M 13.54B |
---|---|---|---|---|---|
Net income 2024 * | -19M -1.5B | Net income 2025 * | -16M -1.26B | EV / Sales 2024 * | 5.82 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.88 x |
P/E ratio 2024 * |
-8.89
x | P/E ratio 2025 * |
-11.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.12% |
Latest transcript on Stereotaxis Inc
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 28/09/16 | |
Kimberly Peery
DFI | Director of Finance/CFO | 55 | 31/12/02 |
Laura Garth
LAW | General Counsel | - | 31/12/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Messey
BRD | Director/Board Member | 78 | 30/04/05 |
Chief Executive Officer | 57 | 28/09/16 | |
Nathan Fischel
BRD | Director/Board Member | 68 | 02/02/17 |
1st Jan change | Capi. | |
---|---|---|
+13.25% | 227B | |
+13.88% | 192B | |
+17.86% | 136B | |
+28.47% | 108B | |
+1.67% | 64.07B | |
+17.55% | 52.1B | |
+7.04% | 51.87B | |
+10.78% | 44.33B | |
+5.44% | 36.75B |